Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer

Single-nucleotide polymorphisms (SNPs) can severely impact individual drug response and health outcomes in cancer patients. Genetic tests to screen for marker SNPs are available to adjust the drug dose of oncologicals to the patient’s needs. However, it is unclear whether the positive effects outbal...

Descripción completa

Detalles Bibliográficos
Autores principales: Szucs, Thomas D, Szillat, Kevin P, Blozik, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923251/
https://www.ncbi.nlm.nih.gov/pubmed/29731658
http://dx.doi.org/10.2147/PGPM.S154368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923251/
https://www.ncbi.nlm.nih.gov/pubmed/29731658
http://dx.doi.org/10.2147/PGPM.S154368

Ejemplares similares